Results 221 to 230 of about 93,900,112 (260)

Every-Other-Day Interferon Beta-1b Versus Once-Weekly Interferon Beta-1a for Multiple Sclerosis: Results of a 2-Year Prospective Randomised Multicentre Study (INCOMIN)

Lancet, The, 2002
Mauro Bergui, Luca Durelli, Pierangelo Barbero   +2 more
exaly  

Targeted Elimination of Senescent Beta Cells Prevents Type 1 Diabetes

Cell Metabolism, 2019
Ajit shah, Mark A Atkinson, Vasilis Ntranos   +2 more
exaly  

Improved Survival Outcomes With the Incidental Use of Beta-Blockers Among Patients With Non-Small-Cell Lung Cancer Treated With Definitive Radiation Therapy

Annals of Oncology, 2013
D R Gomez, J W Welsh, J Y Chang
exaly  

What's New in Antibiotic Resistance? Focus on Beta-Lactamases

Drug Resistance Updates, 2006
Robert A Bonomo, Andrea M Hujer
exaly  

Neutrino–Nuclear Responses for Astro-Neutrinos, Single Beta Decays and Double Beta Decays

Physics Reports, 2019
Kai Zuber, Jouni Suhonen, Hiroyasu Ejiri
exaly  

Interferon Beta-1a and Beta-1b for Treatment of Multiple Sclerosis

Lancet, The, 2002
Michael Benatar
exaly   +2 more sources

Evidence for Down-Regulation of Beta-2-Adrenoceptors in Cirrhotic Patients With Severe Ascites.

Lancet, The, 1986
Tilman Sauerbruch, Gustav Paumgartner, Alexander Gerbes   +2 more
exaly  

Virgin Beta Cells Persist Throughout Life at a Neogenic Niche Within Pancreatic Islets

Cell Metabolism, 2017
Klaus H. Kaestner, Amanda M Ackermann, Mark O Huising   +2 more
exaly  

On Having No Beta-Lipoprotein a Syndrome Comprising A-Beta-Lipoproteinæmia, Acanthocytosis, and Steatorrhœa

Lancet, The, 1960
O H Wolff, J K Lloyd, O H Wolff
exaly  

Clinical Importance of Neutralising Antibodies Against Interferon Beta in Patients With Relapsing-Remitting Multiple Sclerosis

Lancet, The, 2003
Egon Stenager, Thor Petersen, Per Soelberg Sørensen   +2 more
exaly